Drug discovery for Alzheimer's disease: the end of the beginning.
The Institute for the Study of Aging, New York, NY, USA. Lrefolod@aging-institute.org
Lorenzo M
LM
Refolo
Howard M
HM
Fillit
D000047:Academies and Institutes / Q000266:history / Q000639:trends*; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D001921:Brain / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D015195:Drug Design; D004358:Drug Therapy / Q000191:economics / Q000639:trends; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D033183:Interdisciplinary Communication; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use
D018696:Neuroprotective Agents